GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioVaxys Technology Corp (OTCPK:BVAXF) » Definitions » Days Inventory

BioVaxys Technology (BioVaxys Technology) Days Inventory : 0.00 (As of Jul. 2023)


View and export this data going back to 2018. Start your Free Trial

What is BioVaxys Technology Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). BioVaxys Technology's Average Total Inventories for the three months ended in Jul. 2023 was $0.00 Mil. BioVaxys Technology's Cost of Goods Sold for the three months ended in Jul. 2023 was $0.00 Mil.

The historical rank and industry rank for BioVaxys Technology's Days Inventory or its related term are showing as below:

BVAXF's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 193.86
* Ranked among companies with meaningful Days Inventory only.

BioVaxys Technology's Days Inventory stayed the same from Jul. 2022 (0.00) to Jul. 2023 (0.00).

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.


BioVaxys Technology Days Inventory Historical Data

The historical data trend for BioVaxys Technology's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioVaxys Technology Days Inventory Chart

BioVaxys Technology Annual Data
Trend Oct18 Oct19 Oct20 Oct21 Oct22
Days Inventory
- - - - -

BioVaxys Technology Quarterly Data
Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of BioVaxys Technology's Days Inventory

For the Biotechnology subindustry, BioVaxys Technology's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioVaxys Technology's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioVaxys Technology's Days Inventory distribution charts can be found below:

* The bar in red indicates where BioVaxys Technology's Days Inventory falls into.



BioVaxys Technology Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

BioVaxys Technology's Days Inventory for the fiscal year that ended in Oct. 2022 is calculated as

Days Inventory (A: Oct. 2022 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Oct. 2021 ) + Total Inventories (A: Oct. 2022 )) / count ) / Cost of Goods Sold (A: Oct. 2022 )*Days in Period
=( (0 + 0) / 1 ) / 0*365
=0 / 0*365
=N/A

BioVaxys Technology's Days Inventory for the quarter that ended in Jul. 2023 is calculated as:

Days Inventory (Q: Jul. 2023 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Apr. 2023 ) + Total Inventories (Q: Jul. 2023 )) / count ) / Cost of Goods Sold (Q: Jul. 2023 )*Days in Period
=( (0 + 0) / 1 ) / 0*365 / 4
=0 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioVaxys Technology  (OTCPK:BVAXF) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

BioVaxys Technology's Inventory Turnover for the three months ended in Jul. 2023 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

BioVaxys Technology's Inventory to Revenue for the three months ended in Jul. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


BioVaxys Technology Days Inventory Related Terms

Thank you for viewing the detailed overview of BioVaxys Technology's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


BioVaxys Technology (BioVaxys Technology) Business Description

Traded in Other Exchanges
Address
146 Thirtieth Street, Suite 100, Etobicoke, ON, CAN, M8W 3D4
BioVaxys Technology Corp is a clinical-stage biopharma company. The company develops antiviral and anticancer vaccine platforms to treat SARS-CoV-2 and other viral infections, as well as ovarian cancer and other solid tumor types.